Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1136studies shown
Showing 13-24 of 1,136
Drug study icon
RecruitingNCT06887192

ML-007C-MA for Schizophrenia

This study is recruiting in the United States, in France, in Canada, .... It is testing ML-007C-MA for Schizophrenia.

In Canada
SchizophreniaDrugA study involving a medication or substance.From 55 Years to 90 Years
Countries
United States, France, Canada, ...
Sponsor
MapLight Therapeutics
Condition
Schizophrenia
Drug study icon
RecruitingNCT06947941

Safety and Efficacy of KarXT + KarX-EC for Schizophrenia

This study is recruiting in the United States, in Australia, in Canada, .... It is testing Safety and Efficacy of KarXT + KarX-EC for Schizophrenia.

In Canada
SchizophreniaDrugFrom 55 Years to 90 Years
Countries
United States, Australia, Canada, ...
Sponsor
Bristol-Myers Squibb
Condition
Schizophrenia
Drug study icon
RecruitingNCT07424404

KarXT and KarX-EC for schizophrenia

This study is recruiting in the United States, in France, in Canada, .... It is testing KarXT and KarX-EC for schizophrenia.

In Canada
SchizophreniaDrugFrom 5 Years to 17 Years
Countries
United States, France, Canada, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Drug study icon
RecruitingNCT07196501

Maintenance Effect of NBI-1065845 for depression

This study is recruiting in the United States, in Australia, in Canada, .... It is testing Maintenance Effect of NBI-1065845 for depression.

In Canada
DepressionDrugOver 18 Years
Countries
United States, Australia, Canada, ...
Sponsor
Neurocrine Biosciences
Condition
Depression
Behavioral study icon
RecruitingNCT07292883

Accelerated dTMS Smoking Cessation

This summary needs review. Please check the official study record and contact the research team for details.

In Canada
AddictionBehavioralOver 18 Years
Countries
Canada
Sponsor
Waypoint Centre for Mental Health Care
Condition
Addiction
Device study icon
RecruitingNCT07212465

Accelerated Neuromodulation of Anterior Cingulate Cortex for Depression

This study is comparing Active Brainsway H7-Coil Deep TMS System with 20-40 sessions of sham stimulation for people with depression. Participants receive Active Brainsway H7-Coil Deep TMS System or 20-40 sessions of sham stimulation and complete study visits and assessments.

In Canada
DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 60 Years to 85 Years
Countries
Canada
Sponsor
Rotman Research Institute at Baycrest
Condition
Depression
Device study icon
RecruitingNCT07428460

Accelerated Neuromodulation Therapy for Negative Symptoms of Schizophrenia

This study is looking at whether a digital support tool can help people with Schizophrenia and Predominant Negative Symptoms. Participants take part in the program and complete follow-up questionnaires or assessments.

In Canada
SchizophreniaDeviceFrom 18 Years to 65 Years
Countries
Canada
Sponsor
Douglas Mental Health University Institute
Condition
Schizophrenia
Device study icon
RecruitingNCT06854367

Accelerated vs. Conventional Theta Burst Stimulation for Late-life Depression

This study is looking at care and outcomes for people with Late Life Depression, Depression - depression, or depression, Treatment-Resistant. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

In Canada
DepressionDeviceOver 60 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Depression
Drug study icon
RecruitingNCT06620276

ACT_for Addiction and Depression

This observational study is looking at how cognitive behavioural therapy works for people with Depression - depression or Addiction in routine care. Participants are followed through routine care so researchers can learn from the treatment and outcomes already taking place.

In Canada
Depression, AddictionDrugFrom 18 Years to 70 Years
Countries
Canada
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Condition
Depression, Addiction
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.